Antibodies to liver cytosol antigen type 1 (anti-LCl), which recognize a 60-kd peptide contained in the liver cytosolic fraction, have been reported to define a subset of autoimmune hepatitis (AIH) either negative for other autoantibodies or positive for anti-liver kidney micro-soma1 antibody type 1
Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2
✍ Scribed by Eric Martini; Nisen Abuaf; Florence Cavalli; VÉRonique Durand; Catherine Johanet; Prof. Jean-Claude Homberg
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 626 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
An autoantibody to liver cytosol was previously described in childhood autoimmune chronic active hepatitis type 2. The antigen, liver cytosol antigen type 1, was for the first time partially purified using gel filtration and ion exchange chromatography, and it was characterized using immunodiffusion
We describe two patients with liver kidney microsomal antibody type 1 (LKM1)-positive autoimmune hepatitis (AIH) with associated endocrinopathies. The first patient had insulin-dependent diabetes (IDDM), and the second patient had Addison's disease and hypoparathyroidism, and is also positive for is
## Abstract Antibodies to the hepatitis C virus (HCV) core of various immunoglobulin classes were determined by enzyme immunoassays with three synthetic peptides, CP14 (amino acids 5‐40 of the core protein), CP10 (5‐23), and CP9 (39‐74). In 135 patients with chronic type C liver disease, anti‐CPU,
Interferon (IFN) alfa has been used widely for the treatment of chronic hepatitis C virus (HCV) infections but only a small number of patients treated have shown a sustained biochemical and virological response. Anti-envelope E1 and E2 antibody titers were assessed retrospectively before, during, an